Derek Meisner
2021 - X4 Pharmaceuticals
In 2021, Derek Meisner earned a total compensation of $1M as Chief Legal Officer and Corporate Secretary at X4 Pharmaceuticals, a 7% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $184,338 |
|---|---|
| Salary | $428,173 |
| Stock Awards | $415,234 |
| Other | $11,524 |
| Total | $1,039,269 |
Meisner received $428.2K in salary, accounting for 41% of the total pay in 2021.
Meisner also received $184.3K in non-equity incentive plan, $415.2K in stock awards and $11.5K in other compensation.
Rankings
In 2021, Derek Meisner's compensation ranked 8,669th out of 12,406 executives tracked by ExecPay. In other words, Meisner earned more than 30.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,669 out of 12,406 | 30th |
Division Manufacturing | 3,843 out of 5,492 | 30th |
Major group Chemicals And Allied Products | 1,697 out of 2,368 | 28th |
Industry group Drugs | 1,510 out of 2,089 | 28th |
Industry Biological Products, Except Diagnostic Substances | 330 out of 452 | 27th |
Source: SEC filing on April 25, 2022.
Meisner's colleagues
We found two more compensation records of executives who worked with Derek Meisner at X4 Pharmaceuticals in 2021.
News
Acumen Pharmaceuticals CEO Daniel O'Connell's 2023 pay jumps 48% to $3.9M
April 22, 2024
Acumen Pharmaceuticals CEO Daniel O'Connell's 2022 pay jumps 80% to $2.7M
April 27, 2023
X4 Pharmaceuticals CEO Paula Ragan's 2021 pay slips 15% to $2.1M
April 25, 2022
X4 Pharmaceuticals CEO Paula Ragan's 2020 pay rises 1% to $2.5M
April 20, 2021